Showing results (191-200 of 214) with videos related to
Sort By:
Pageof 22
Journal of Oncology Practice|September 23, 2010
Benchmarks in clinical productivity: a national comprehensive cancer network surveyF Marc Stewart, Robert L Wasserman, Clara D Bloomfield, et al.The Journal of Allergy and Clinical Immunology. in Practice|March 16, 2024
Age-Related Food Aversion and Anxiety Represent Primary Patient Barriers to Food Oral ImmunotherapyJordan Trevisonno, Carina Venter, Kaci Pickett-Nairne, et al.The Journal of Allergy and Clinical Immunology|September 22, 2009
Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacksTimothy J Craig, Robyn J Levy, Richard L Wasserman, et al.Journal of Clinical Immunology|May 18, 2006
Efficacy, safety and tolerability of a new 10% liquid intravenous immune globulin [IGIV 10%] in patients with primary immunodeficiencyJoseph A Church, Heinz Leibl, Mark R Stein, et al.Journal of Clinical Immunology|May 26, 2016
Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary ImmunodeficiencyRichard L Wasserman, Isaac Melamed, Mark R Stein, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 3, 2010
Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacksJonathan A Bernstein, Bruce Ritchie, Robyn J Levy, et al.The Journal of Allergy and Clinical Immunology. in Practice|March 8, 2021
An Approach to the Office-Based Practice of Food Oral ImmunotherapyRichard L Wasserman, Jeffrey Factor, Hugh H Windom, et al.Allergy and Asthma Proceedings|January 26, 2011
Hereditary angioedema: Validation of the end point time to onset of relief by correlation with symptom intensityJonathan A Bernstein, Bruce Ritchie, Robyn J Levy, et al.Frontiers in Allergy|January 26, 2023
Towards an FDA-cleared basophil activation testOral Alpan, Richard L Wasserman, Theodore Kim, et al.The Journal of Allergy and Clinical Immunology|April 4, 2006
Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and ImmunologyJordan S Orange, Elham M Hossny, Catherine R Weiler, et al.Pageof 22